Witnesses describe deadly apartment shooting as 2 jurors are dismissed in Zollicoffer trial
CBS 58 MILWAUKEE (CBS 58) -- Five people who were inside a Milwaukee apartment on Aug. 8 testified on Tuesday, Nov. 17 in the trial of Thomas Zollicoffer, who faces seven felony charges in the fatal shootings of three people at two locations.
Witnesses testified that about eight people were partying in the apartment near 21st and Pierce when Zollicoffer showed up uninvited. They described him as tense and saying mean things to his ex-girlfriend, Vanessa Deherrera, before he grabbed a gun the group asked him to put away and shot her. Scott Bucholz then exclaimed, and Zollicoffer shot him, according to the testimony.
Deherrera and Bucholz died.
One witness, whom CBS 58 is not naming, testified, "He said, 'That's what you get for playing with me,' and he shot her a few times while she was on the floor." The witness later ran from the living room into a bedroom, passing Deherrera's body.
"She was gasping. And I couldn't do anything," the witness said while crying, "because I didn't know if he was still there or not and I was afraid if I went to help or talk to her that he would shoot me. So, I had to just listen."
Zollicoffer allegedly used a jail-issued electronic device to discuss threatening witnesses, which drew controversy before the trial.
Deherrera's and Bucholz's families cried as they heard the testimony and saw crime scene photos, which CBS 58 is not sharing.
The state has called only witnesses from the first shooting location so far. Testimony is expected in the coming days about the death of Shamarla Asir Hare, who Zollicoffer is accused of fatally shooting at a second location.
Juror issue on Tuesday, Nov. 17
Before the case resumed on Tuesday, two jurors were unable to come in. One was very sick and going to the doctor but willing to come in if needed. The other was described as "MIA" and "refusing to come in and cooperate." Both jurors were excused, which leaves 12 jurors and no alternates on the second day of a trial expected to last all week.